SAB Biotherapeutics, Inc.

NASDAQ
SABS
paper.types.company
Rentabilité sur six mois: -39.73%
Rendement en dividendes: 0%
Secteur: Healthcare

1.76 $

-0.02 $ -1.12%
1.11 $
4.65 $

paper.min_max_per_year

Calendrier des promotions SAB Biotherapeutics, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at infectious diseases and immune and autoimmune disorders, including infectious diseases, influenza, CDI, type 1 diabetes, organ transplantation, and oncology, as well as immunology, gastroenterology, and respiratory diseases.

plus de détails
The company also uses its DiversitAb immunotherapy platform to produce fully-human polyclonal antibodies without the need for human donors or plasma. In addition, its lead product candidates include SAB-185, a fully-human polyclonal antibody therapeutic candidate that is in Phase III clinical trial for the treatment of COVID-19; and SAB-176, a fully-human polyclonal antibody therapeutic candidate that is in development for the treatment or prevention of severe influenza. Further, the company's pre-clinical product candidates in development for autoimmune diseases include SAB-142 for type 1 diabetes and organ transplant induction/rejection. SAB Biotherapeutics, Inc. was founded in 2014 and is headquartered in Sioux Falls, South Dakota.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

Paramètres de base

IPO date
2021-02-09
ISIN
US78397T1034
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
lien
Tous les paramètres

Grade

Sous-estimation
Nom Signification Grade
P/S 26.57 1
P/BV 1.35 9
P/E 0 0
Efficacité
Nom Signification Grade
ROA -53.23 0
ROE -81.92 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.161 10
Debt/Ratio 0.1056 10
Debt/Equity 0.7018 9
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % -97.6 0
Rentabilité Ebitda, % -237.41 0
Rentabilité EPS, % -895.83 0
Plus de détails

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 1.78 $ 0 $ 0 $ -1.12 % 0 % 0 %
common.calendar.number_days.7d 1.86 $ 0 $ 0 $ -5.38 % 0 % 0 %
common.calendar.number_days.30d 1.66 $ 1.71 $ 1.98 $ 6.34 % 0 % 0 %
common.calendar.number_days.90d 1.69 $ 1.11 $ 1.98 $ 4.14 % 0 % 0 %
common.calendar.number_days.180d 2.92 $ 1.11 $ 4.65 $ -39.73 % 0 % 0 %
common.calendar.number_days.1y 2.64 $ 1.11 $ 4.65 $ -33.33 % 0 % 0 %
common.calendar.number_days.3y 1.94 $ 0.38 $ 70 $ -9.28 % 0 % 0 %
common.calendar.number_days.5y 0 $ 0.38 $ 70 $ 0 % 0 % 0 %
common.calendar.number_days.10y 0 $ 0.38 $ 70 $ 0 % 0 % 0 %
common.calendar.number_days.ytd 4.28 $ 1.11 $ 4.36 $ -58.88 % 0 % 0 %

Principaux propriétaires

Entreprises similaires

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Samuel J. Reich CEO & Executive Chairman 363.2k 1975 (50 années)
Dr. Eddie Joe Sullivan Ph.D. Co-Founder, President & Director 402.56k 1966 (59 années)
Ms. Christine E. Hamilton M.B.A. Co-Founder & Independent Director 25k 1956 (69 années)
Dr. Alexandra Kropotova M.B.A., M.D. Executive VP & Chief Medical Officer 774.45k 1973 (52 année)
Dr. Edward D. Hamilton D.V.M. Co-Founder & Board Observer N/A
Dr. Christoph Bausch M.B.A., Ph.D. Executive VP & COO 443.2k 1971 (54 année)
Dr. Carlos N. Carillo Ph.D. Senior Vice President of Regulatory Affairs N/A
Mr. Mark W. Conley Interim Chief Financial Officer

Informations sur l'entreprise

Adresse: United States, Sioux Falls. SD, 2100 East 54th Street North - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.sabbiotherapeutics.com